Guardant360 CDx is approved to identify ESR1 mutations in advanced breast cancer, aiding treatment with Inluriyo. Inluriyo showed a 38% lower risk of disease progression in the EMBER-3 trial compared ...

Overall, the median duration of b/tsDMARD use was 4.3 years, longer in RA (6.3 years) than axSpA (3 years). TNF inhibitors ...

Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...

Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

But a new generation of noninvasive tests are emerging that could help accelerate diagnosis and improve management of this ...

Standard cancer screenings in the U.S. overlook nearly 70% of cancers and cancer subtypes. Multiple-cancer early detection (MCED) blood tests can help identify cancer biomarkers for multiple cancer ...

Data at ESMO 2025 bolstered the case that blood tests could help doctors sort which patients need additional therapy, and who ...

Emory researchers discovered blood changes that could allow Alzheimer’s to be detected years before symptoms appear.

Cleveland Elementary School teacher Katia Rodriguez-Mester, left, shows an mCLASS reading test to Principal Gabriel Sandoval and Denise Alvarado, executive director of elementary education for the ...

A daily close above $24, alongside a lower Exchange Supply Ratio and sustained whale demand, could extend the rally.